• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC SAFETY INFUSION SET 20G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC SAFETY INFUSION SET 20G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/17/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The date of event was not provided by the complainant/reporter, the date reflected in this report is the date bd became aware of the event.The manufacturer has received the sample and will evaluate.Results are expected soon.
 
Event or Problem Description
It was reported, ¿powerloc safety infusion set have leaked at the base of the needle.Luckily, they were caught while priming the needle, prior to accessing the patient.¿ no other information was provided.It was reported this occurred with two devices.This report addresses the second device.
 
Event or Problem Description
It was reported, ¿powerloc safety infusion set have leaked at the base of the needle.Luckily, they were caught while priming the needle, prior to accessing the patient.¿ no other information was provided.It was reported this occurred with two devices.This report addresses the second device.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The complaint of a leaking infusion set was confirmed and the cause was determined to be supplier related.The product returned for evaluation was two 20g powerloc infusion sets.The investigation findings were consistent with improper or insufficient adhesive application or curing during manufacture of the component.The returned product sample was evaluated and a leak was observed in one of the two returned units (unit 02) at the junction between the extension tubing and the needle housing.This investigation concluded that the adhesive had not established a sufficient bond between the extension tubing and the needle housing, and the characteristics observed which supported this type of failure included: ¿ air bubbles or voids in adhesive coverage were seen in the proximal application well.¿ voids or gaps in adhesive coverage were observed on the extension tubing.This is a supplied component and the supplier has been notified of this event.H3 other text : evaluation findings in section h:11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC SAFETY INFUSION SET 20G X 0.75IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
maddy vincent
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key18682679
Report Number3006260740-2024-00442
Device Sequence Number12589939
Product Code FPA
UDI-Device Identifier00801741047763
UDI-Public(01)00801741047763
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K060812
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number0652034
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/29/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/17/2024
Supplement Date Received by Manufacturer03/18/2024
Initial Report FDA Received Date02/10/2024
Supplement Report FDA Received Date04/12/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-